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Summary
MRL-Ipr/lpr mice develop a severe autoimmune disease that resembles systemic lupus erythema-
tosis in humans. The predominant immunological feature in these mice is the development of
peripheral lymphadenopathy due to the expansion of an unusual T cell subset (TCR
ct//3+5CD3+4-8-B220+), which may be related to the onset of their autoimmunity. However,
it is unknown whether such abnormal lymphocytes proliferate in the specific organs or not.
We demonstrated in the present study that the number of liver nonparenchymal mononuclear
cells (MNC) in the diseased MRL-Ipr/Iprmice was 10 times greater than that ofcontrol MRL- +/+
mice. Moreover, the freshlyisolated liver MNC of MRL-Ipr/lpr mice vigorously proliferated in
vitro and consisted of abnormal CD3+4-8- lymphocytes. Such in vitro proliferation was not
observed in the MNC of other peripheral lymphoid organs. A potent natural cytotoxicity was
also confined to the liver MNC in MRL-1pr/1pr mice. In vivo injection of [3H]TdR demonstrated
that liver MNC incorporated [3H]TdR; such incorporation showed a peak on day 1, and the
MNC-incorporated [3H]TdR appeared in the lymph nodes as late as day 5 after the injection.
These results suggest that the liver is a possible site for the proliferation of abnormal lympho-
cytes, which may migrate thereafter into the peripheral organs in MRL-Ipr/lpr mice.
MRL-Ipr/lpr (MRL/Ipr) , mice develop a severe autoim-
mune disease that resembles SLE and rheumatoid ar-
thritis in humans (1, 2). The predominant immunological
abnormality in these mice is the development of peripheral
lymphadenopathy due to the expansion of an unusual T cell
subset (TCR-ot/R+ CD3+4 - 8 - B220+) . It is well known
that MRL-+/+ (MRL/+) mice also develop autoimmu-
nity when they become old (>40 wk). If lpr/lpr genes are
inserted into these mice (i.e., MRL/lpr), development of se-
vere autoimmune disease in their youth (14 wk) is acceler-
ated, accompanied by prominent lymphadenopathy. It is, there-
fore, postulated that the abnormal double-negative (DN;
CD4 - 8 - ) lymphocytes constituting the lymphadenopathy
may be responsible for the development of autoimmunity (e.g.,
helper function of autoantibody production for B lympho-
cytes and cytotoxicity against autoantigens) (3-7). Despite
enormous accumulation of abnormal lymphocytes in the
lymph nodes and spleen, the cells do not actively proliferate
in these organs (8). As there is also no evidence of increased
proliferation of such lymphocytes in the thymus and bone
marrow, it raises the possibility that this lymphadenopathy
is caused by mere accumulation of such cells in the periph-
'Abbreviations used in this paper. DN, double negative; MNC, mono-
nuclear cells; MRL/Ipr, MRL-1pr/Ipr; MRL/+, MRL-+/+ .
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eral organs (9, 10). However, we reveal here that such ab-
normal lymphocytes proliferate in the liver ofMRL/lpr mice.
Although it is well established that the liver is the major he-
matopoietic organ in the fetal stage (11), the present results
show that the liver is still an important organ for the produc-
tion of certain lymphocytes after birth.
Materials and Methods
Mice.
￿
Female MRL/Ipr and MRL/+ mice, 5-35 wk of age,
were purchased from Charles River Japan, Inc., Japan, and fed under
pathogen-free conditions.
Cell Preparation.
￿
Perfusion was performed to eliminate blood
contained in the liver by gentle injection of 10 ml ofPBS (0.01 M,
pH 7.2) into the portal vein just before removal of the liver (12).
To obtain mononuclear cells (MNC), the liver was removed, cut
into small pieces by scissors, pressed through 100-gauge stainless
steel mesh, and suspended in serum-free RPMI 1640 medium sup-
plemented with antibiotics. This suspension was centrifuged at
250 g for 5 min at 4°C, and the supernatant was removed. The
cell pellet was resuspended in an adequate amount (N20 ml/liver)
ofthe medium, and nonparenchymal MNC were isolated by Ficoll-
Isopaque density (1.090) gradient centrifugation. In the MNC prep-
aration method applied here, the proportion of contaminating
phagocytes (i.e., Kupffer cells) was negligible (<4%), as shown pre-
viously (12). MNC in other lymphoid organs, including the lung
and the intestine, were collected by the Ficoll-Isopaque method,
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and forced through 200-gauge stainless steel mesh (12). Bone
marrow cells were obtained from the femur to flushout the marrow
in conjunction with the Ficoll-Isopaque method (12). Peripheral
blood was collected in a heparinized syringe, and MNC were purified
by the Ficoll-Isopaque method.
DNA Synthesis Assay.
￿
For determination of spontaneous pro-
liferation, 5 x 101 freshly isolated MNC in 200 p.l RPMI medium
supplemented with 1% normal mouse serum and 5 x 10-s M 2-
ME were cultured with 0.5 1ACi of [3H]TdR (Amersham Inter-
national, Amersham, England) for 12 h in a 96-well flat-bottomed
microculture plate (Falcon Labware, Oxnard, CA) at 37°C in a
5% COz incubator (12).
Immunofluorescence Test.
￿
Surface phenotype ofcells was identified
by using mAbs in conjunction with two-color immunofluorescence
tests. The monoclonal reagents used here were fluorescein- or
phycoerythrin-conjugated anti-mouse CD3, CD4 (L3T4), CD8
(Lyt-2), B220, and Va8 of TCR (F23.1) antibodies (12). The fluo-
rescence-positive cells were analyzed by FACScan (Becton Dick-
inson & Co., Mountain View, CA).
Cytotoxicity Assay.
￿
Cytotoxicity was examined by a specific
"Cr-release assayof 4-h incubation analysis (12). Target cells used
in this study included a murine lymphoid tumor cell line, YAC-1.
The E/T ratios examined were 50:1, 25:1, and 12.5 :1.
In Vivo Injection of PH]TdR.
￿
To investigate whether liver
MNC proliferate in vivo in MRL/Ipr mice, each mouse was intra-
venously injected with 740 KBq (0.1 ml of PBS) of ['H]TdR, and
the level of [3H]TdR incorporation/5 x 106 MNC of various lym-
phoid organs was sequentially analyzed. The specific activity of
['H]TdR used here was 185 GBq/mmol.
Results
Increase in Number andSpontaneous Proliferation ofLiverMNC
in MRL/IprMice. We previously established a method for
isolating liver MNC after perfusion with PBS in conjunc-
tion with Ficoll-Isopaque gradient centrifugation (12). This
method was applied to the isolation ofliver MNC in MRL/Ipr
and MRL/+ mice (Table 1). In MRL/Ipr mice, the onset
of disease was at the age of -14 wk. The MRL/lpr and
Table 1 .
￿
Increase in Number and Spontaneous Proliferation ofLiver MNC in Diseased MRL/lpr Mice
MRL/Ipr and MRL/+ mice, aged 15 wk, were used in this experiment. Data are expressed as the mean cpm and 1 SD of triplicate cultures.
Mean ± SD.
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MRL/+ mice used here were 15 wk old. It was demonstrated
that the mean number (x 106) of liver MNC (8.3 ± 1 .0)
in MRL/Ipr mice was 10 times greater than that (0.8 ± 0.1)
in MRL/+ mice. In addition to such an abnormal increase
in the cell number, the [3H]TdR incorporation/5 x 105 cells
(18,314 ± 8,527) was 10 times greater than that (2,666 ±
1,088) in MRL/+ mice. The activity of cell proliferation in
liver MNC of MRL/Ipr mice was estimated to be -100 times
greater than that of control MRL/+ mice. The cell prolifer-
ation assay was then analyzed in liver MNC of MRL/lprmice
of various ages to investigate whether the above result was
related to the diseased state in these mice (Fig. 1). MNC of
the lymph nodes were examined in parallel. The increased
spontaneous proliferation of MNC in the liver, but not the
lymph nodes, was clearly related to the age of the onset of
autoimmunity (Fig. 1 A). Prominent proliferation remained
at a high level during the active stage of their disease, al-
though it declined gradually as a function of age. Prolifera-
tion of MNC in the lymph nodes was not observed during
the entire period. The cell proliferation assay was performed
in various lymphoid organs of MRL/Ipr and MRL/+ mice
aged 15 wk (Fig. 1 B). It was demonstrated that the increased
proliferation of MNC was confined to the liver among the
peripheral lymphoid organs in MRL/Ipr mice. MNC of the
bone marrow, that is the hematopoietic organ, greatly prolifer-
ated in both MRL/Ipr and MRL/+ mice.
Phenotypic Characterization of the Lymphocytes.
￿
The sur-
face phenotype of MNC was analyzed by two-color immu-
nofluorescence tests in various lymphoid organs ofMRL/Ipr
and MRL/+ mice (Fig. 2). Here, MNC was simultaneously
stained with fluorescein-conjugated anti-CD3 antibody and
phycoerythrin-conjugated anti-CD4 and anti-CD8 antibodies
to identify the CD3 +4 - 8 - cells and CD3+4+ (or 8+) cells.
As shown previously (3, 4) and in this study, almost all of
the abnormal CD3+4-8 - DN lymphocytes coexpressed the
B220 antigens. Thus, if phycoerythrin-conjugated B220 an-
tibody was added to the above staining schedule, all of the
green single-color-positive cells disappeared (datanot shown).
Exp .
No . of
MRL/lpr
liver MNC/liver
MRL/ +
[3H]TdR
MRL/Ipr
Incorporation
MRL/ +
x 106 cpm ± SD
1 7.5 0.7 11,620 ± 778 3,258 ± 213
2 8.3 0.9 18,028 ± 162 2,806 ± 143
3 8 .0 0.7 10,878 ± 985 1,094 ± 133
4 7.8 0.7 32,107 ± 4,375 3,507 ± 103
5 10.0 ND 18,930 ± 1,422 ND
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Figure 1.
￿
Spontaneous proliferation of MNC. (A) Age-dependent
appearance of the spontaneous proliferation of liver MNC in
MRLlipr mice. MRL//pr mice, aged 5-35 wk, were used in this ex-
periment. (B) Analysis of the spontaneous proliferation of MNC from
various lymphoid organs. Here, MRL/Ipr and MRL/+ mice aged 15
wk were used. [)H]TdR Incorporation in 5 x 10' cells in a 12-h cul-
ture was analyzed.
As shown in Fig. 2 A, abnormal CD3*4 - 8 - B220* DN
lymphocytes were detected in all peripheral lymphoid organs,
including the liver, of MRL/lpr mice. Such abnormal lym-
phocytes were extremely rare in the thymus and bone marrow.
Such lymphocytes were not detectable at all in control mice.
Some ofthe actual profiles are shown in Fig. 2 B. Liver MNC
consisted of both CD3*4 - $ - DN lymphocytes and
CD3 * 4 * (or 8 * ) lymphocytes, whereas MNC of the lymph
nodes consisted mainly of CD3*4 - 8 - DN lymphocytes.
We then analyzed the phenotype of in vitro proliferating liver
MNC in MRL/lpr mice (Fig. 2 C). As we observed that liver
MNC depleted of CD3 * cells by complement-mediated cell
lysis using anti-CD3 antibody still had the ability to proliferate
in vitro, the phenotype of liver MNC depleted of CD3'
cells was examined before and after a 3-d culturing. The liver
MNC depleted of CD3 * cells initially lacked the CD3,
CD4, CD8, and TCR-a/0 antigens (<4%) . After the cul-
ture, the prominently increased expression of CD3 and TCR-
a/(3 antigens (up to 14%), but not of CD4 and CD8 an-
tigens (see the bottom of Fig. 2 C), was demonstrated. Here,
the actual increase of the cell number was -1 .5-fold for the
3-d culture.
Time Kinetics ofthe Appearance ofMNC-incorporated (jH]-
TdR in Various Lymphoid Organs . To confirm that liver
MNC actually proliferated in vivo in MRL/lpr mice, each
mouse was intravenously injected with [3H]TdR, and the
level of [3H]TdR incorporation/5 x 106 MNC of various
lymphoid organs was sequentially analyzed {Fig. 3}. The liver
MNC were demonstrated to incorporate ['H]TdR at a level
almost comparable with that ofbone marrow cells, showing
a peak on day 1. MNC in the spleen were shown to have
a considerable level of [3H]TdR incorporation as well,
whereas that of the thymus was at the basal level during the
entire period tested. Of particular interest was that MNC
in the lymph nodes showed a peak of radioactivity on day
5. As significant radioactivity was not detected in the serum
on days 4 and 5 (Fig. 3, dotted line), such MNC-incorporated
['H]TdR in the lymph nodes most probably originates
in other lymphoid organs where cell proliferation occurs.
Cells that incorporated [3H]TdR were demonstrated to be
CD3*4 - 8 - cells, since the complement-mediated cell lysis
using both anti-CD4 and -CD8 antibodies did not reduce
the radioactivity (data not shown). On the other hand, such
prominent in vivo [3H]TdR incorporation was not seen in
MNC from any peripheral lymphoid tissues ofMRL/+ con-
trol mice. Concerning the unique results of liver MNC of
MRL/lpr mice in in vitro and in vivo studies, it is conceiv-
able that MNC-incorporated [3H]TdR in the liver might
migrate to the lymph nodes.
Cytotoxicity ofLiverMNC.
￿
It has been previously demon-
strated that liver MNC in MRL/Ipr mice have potent ryto-
toxic activity against tumor target cells (13). We further ex-
amined whether such high rytotoxic activity was confined
to liver MNC. The rytotoxic function against YAC-1 tumor
cells was examined by a specific "Cr-release assay of a 4-h
analysis. The increased rytotoxicity was restricted to the liver
MNC in MRL/lpr mice (Table 2). The complement-mediated
cytolysis by using anti-asialo GMt and anti-CD3 antibod-
ies revealed that not only asialo GM) * NK cells but also
CD3+4 - 8 - cells mediated rytotoxicity against the NK-resis-
tant target (data not shown) .
Discussion
In the present study, we demonstrated that the number
of liver MNC in the diseased MRL/Ipr mice was 10 times
greater than that of control MRL/+ mice. Moreover, the
isolated liver MNC of MRL/lpr mice vigorously proliferate
in vitro and:-consisted of abnormal CD3*4 - 8 - DN lym-
phocytes:. In a morphological study, we also observed that
>70% of MNC -in the hepatic sinusoid were lymphoblastic
in MRL/lpr mice, whereas almost all MNC (>95%) in the
lymph nodes were small resting lymphocytes (Masuda et al.,
manuscript in preparation) . It is, therefore, presumed that
liver MNC, including abnormal DN lymphocytes, are in anFigure 2 .
￿
Analysis of surface phenotype of MNC . (A) Comparison
of the distribution of CD3'4-8 - B220' DN lymphocytes in various
lymphoid organs between MRL/Ipr and MRL/ + mice . (B) Two-
color profiles of MNC in the liver and lymph nodes from MRL/Ipr
mice. (C) Expansion of CD3' and TCR ~' cells from liver MNC in
MRL/Ipr mice; before culture (---- ) and after culture (-) . As ab-
normal CD3'4 - 8 - DN lymphocytes were always accompanied by the
B220 antigens in MRL/Ipr mice, we represented them as
CD3'4 -8 - B220' cells in this figure. In two-color profiles, the or-
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Figure 3 .
￿
Time kinetics of the appearance of MNC-incorporated
[3H]TdR in various lymphoid organs of MRL/Ipr mice . 740 KBq of
[3H]TdR was intravenously injected to each MRL/Ipr mouse, aged 15
wks, and the level of [3H]TdR incorporation into 5 x 106 MNC of
various lymphoid organs was sequentially analyzed up to 11 d after
the injection . Each plot was produced by the mean value of MNC
collected from two or three mice . The [ 3H]TdR levels of 2 .5 pl of
serum were represented as a dotted line.
active state in terms of both cell proliferation and cytotoxic
function . This raises the possibility that such cells may be
responsible for the destruction of autologous cells in autoim-
mune disease when they migrate to the periphery. MNC in
the spleen seem to have an intermediate feature between MNC
in the liver and in the lymph nodes, with respect to their
proliferation and cytotoxic activity. The results of in vivo
[3H]TdR injection experiments suggest that hepatic DN
lymphocytes may be a source of abnormal lymphocytes con-
stituting the lymphadenopathy of lymph nodes .
We previously established thatMNC could be isolated from
liver of mice after perfusion with PBS from the portal vein,
in conjunction with Ficoll-Isopaque gradient centrifugation
(12) . The isolated MNC mainly consisted ofT lymphocytes
and NK cells, but only a small proportion of Kupffer cells
(<4%) . When we estimated the number of hepatic MNC
in a small aliquot of the mixed cell suspection (i.e., the mix-
ture ofhepatocytes and hepatic MNC) before the application
ofgradient centrifugation, the number of hepaticMNC was
approximately five times greater than that of hepatic MNC
after application of gradient centrifugation . Such a cell yield
was not variable between MRL/Ipr and MRL/+ mice . As
the cell yield of liverMNC isolated by the present method
was X20%, the actual cell number of liverMNC in the dis-
eased MRL/Ipr mice was -4 x 10' cells/liver. This number
dinate is indicated by green (fluorescein) and the abscissa is indicated
by red (phycoerythrin) . Complement-mediated cell lysis was applied
to eliminate CD3', CD4', or CD8' cells in conjunction with un-
conjugated aliquots of the anti-CD3, CD4 (L3T4), and CD8 (Lyt-2)
antibodies (murine IgM or IgG2b), which are complement-fixing re-
agents . Here, the anti-CD3 antibody was murine IgM and was not
mitogenic for T lymphocytes.Table 2.
￿
A comparison ofthe Cytotoxicity ofMNC in Various
Lymphoid Organs between MRLllpr and MRLI+ Mice
MRL/Ipr and MRL/ + mice, aged 15 wk, were used in this experi-
ment. Data are expressed as the mean percent cytotoxicity of tripli-
cate assays.
' E/T ratio.
is almost comparablewith that of the spleen in normal young
adult mice feeding under pathogen-free conditions. On the
other hand, the number of liver MNC (ti4 x 106 cells/
liver) in MRL/+ mice was comparable with those of other
strains of mice, as shown in our previous study (12).
In the in vitro culture system, we observed that liver MNC
depleted of CD3+ cells still had the ability to proliferate, and
that the prominent increased expression of CD3 and TCR-
cx/(3 antigens, but not ofCD4 and CD8 antigens, was demon-
strated. TCRcx//3+CD3+4 -8 - cells, therefore, might expand
from either null cell precursors or a minor remaining popu-
lation of TCR-cx/(3+CD3+4 - 8 - cells. On the other hand,
we could not induce in vitro such TCR-ct/a+CD3+4 - 8 -
cells from bone marrow cells in MRL/Ipr mice. It is conceiv-
able that, even if the earliest precursors ofabnormal lympho-
cytes themselves come from the bone marrow (14), such lym-
phocytes may have to encounter hepatic microenvironments
for maximum expansion.
There are several reports that neonatal thymectomy sig-
nificantly reduces the lymphadenopathy and autoimmunity
in MRL/Ipr mice (15-17). However, there is no evidence that
abnormal lymphocytes proliferate in the thymus based on the
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results of the present in vitro and in vivo studies. Therefore,
two possibilities can be proposed to explain this phenomenon.
The first possibility is that the precursor cells of abnormal
lymphocytes in the bone marrow of MRL/Ipr mice pass
through the thymus and proliferate in the liver. Even in this
case, the thymus may not be a major site for the expansion
of these cells. The second possibility is that abnormal lym-
phocytes in the liver may directly come from the bone marrow
and be generated by entirely extrathymic proliferation. Thus,
the liver MNC depleted of CD3+ cells in MRL/lpr mice are
still able to proliferate in vitro and produce CD3+4 - 8 - DN
lymphocytes. In this case, as abnormal TCR-ct/0+ DN lym-
phocytes are generated in the liver, it is easy to consider that
such cellsmay be autoreactive due to the escape from thymic
education. In recent studies, the possibility of extrathymic
maturation of TCR-ct/R+ and TCR,y/S+ cells has been
shown.(18-20). There is also an earlier report that the trans-
plantation of the thymus from a normal mouse to a thymec-
tomized MRL/Ipr mouse did not prevent lymphadenopathy
and autoimmunity (16). This experimental result also seems
to support the second possibility. In this case, we prefer to
consider the possibility that normal CD4+ (and/or CD8+)
cells, which come from the thymus and are abundant in the
liver of MRL/Ipr mice (Fig. 2, A and B), may support the
growth of abnormal lymphocytes in the liver, since the per-
centages of normal CD4+ and CD8+ cells existing in the
liver, spleen, and lymph nodescorrelate well with the prolifer-
ation activity of CD3+4 - 8 - cellsin these organs. This con-
ception is supported by several reports that anti-CD4 anti-
body treatment in vivo reduced the onset of autoimmunity
in MRL/Ipr mice (21, 22).
We have recently demonstrated that liver MNC, in not
only aged MRL/+ mice (>40 wk of age), but also in other
autoimmune mice such as BXSB and NZB/W Fl strains, are
characterized by increased cell proliferation activity accom-
panying the increased number of liverMNC (Ohteki et al.,
unpublished observation) . This evidence suggests that the
liver may be the most important site for proliferation of ab-
normal autoreactive lymphocytes in mice with a wide range
of autoimmune diseases. However, the above autoimmune
mice do not show prominent lymphadenopathy in the pe-
ripheral lymphoid organs. It is, therefore, conceivable that
MRL/Ipr mice have an additional feature, such as the accumu-
lation of abnormal lymphocytes in the peripheral lymphoid
organs, probably due to the homing abnormality of such lym-
phocytes, that may be responsible for the acceleration of their
autoimmunity (10) . As increased TCRcx/a+ DN cells were
also demonstrated in the patients with SLE (7), whether such
lymphocytes also proliferate in the liver of patients with au-
toimmune diseases is under investigation.
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